Ayala Pharmaceuticals Inc. (ADXS)
OTCMKTS: ADXS · Delayed Price · USD
0.640
-0.060 (-8.57%)
Mar 28, 2024, 3:03 PM EDT - Market closed

Ayala Pharmaceuticals Income Statement

Millions USD. Fiscal year is Nov - Oct.
Year 2022202120202019201820172016201520142013 2012 - 2002
Revenue
0.253.240.252.336.0612.033.99010
Upgrade
Revenue Growth (YoY)
-92.28%1180.63%-89.16%-61.50%-49.61%201.16%----
Upgrade
Cost of Revenue
0.313.711.291.29000000
Upgrade
Gross Profit
-0.06-0.47-1.031.056.0612.033.99010
Upgrade
Selling, General & Admin
8.4211.4611.094.3419.4738.6631.7124.4511.859.07
Upgrade
Research & Development
7.6110.5615.6114.4256.9771.948.7724.228.695.62
Upgrade
Other Operating Expenses
3.05-0-00-0.06-0-0-0.040.01-3.53
Upgrade
Operating Expenses
16.0322.0326.718.7676.44110.5680.4948.6720.5414.69
Upgrade
Operating Income
-16.09-18.79-26.45-17.71-70.38-98.53-76.49-48.67-19.54-14.69
Upgrade
Interest Income
0.160.010.110.230.580.670.330.110.040.01
Upgrade
Interest Expense
00.260000000.010.99
Upgrade
Other Expense / Income
-1.62-1.230.08--3.34-0.02-0.070.08-0.635.04
Upgrade
Pretax Income
-14.31-17.81-26.42-17.49-66.47-97.84-76.09-48.64-18.88-20.71
Upgrade
Income Tax
0.050.050.050.310.05-4.4-2.54-1.61-2.36-0.73
Upgrade
Net Income
-14.36-17.86-26.47-17.79-66.52-93.44-73.56-47.03-16.53-19.99
Upgrade
Shares Outstanding (Basic)
2219000000
Upgrade
Shares Outstanding (Diluted)
2219000000
Upgrade
Shares Change
12.70%111.61%-91.11%19884.51%27.13%14.48%26.31%63.84%241.36%95.41%
Upgrade
EPS (Basic)
-7.90-11.07-34.71-2.07-1549.20-2766.57-2493.43-2013.75-1159.26-4786.12
Upgrade
EPS (Diluted)
-7.90-11.07-34.71-2.07-1549.20-2766.57-2493.43-2013.75-1159.26-4786.12
Upgrade
Free Cash Flow
-15.49-15.9-22.69-16.28-64.97-81.55-13.52-25.93-17.46-9.01
Upgrade
Free Cash Flow Per Share
-8.51-9.85-29.75-1.90-1513.22-2414.54-458.30-1110.27-1224.93-2158.21
Upgrade
Gross Margin
-25.60%-14.44%-407.91%44.94%100.00%100.00%100.00%-100.00%-
Upgrade
Operating Margin
-6436.00%-579.81%-10454.15%-758.83%-1160.79%-818.95%-1914.77%--1953.86%-
Upgrade
Profit Margin
-5743.60%-551.30%-10462.06%-762.30%-1097.06%-776.62%-1841.27%--1652.53%-
Upgrade
Free Cash Flow Margin
-6194.00%-490.71%-8967.59%-697.51%-1071.58%-677.80%-338.43%--1746.13%-
Upgrade
EBITDA
-15.78-18.77-24.39-17.56-72.28-97.43-76.03-48.36-19.29-18.04
Upgrade
EBITDA Margin
-6310.40%-579.20%-9641.90%-752.40%-1192.12%-809.80%-1903.07%--1929.27%-
Upgrade
Depreciation & Amortization
0.310.991.980.151.51.120.540.270.20.18
Upgrade
EBIT
-16.09-19.76-26.37-17.71-73.78-98.55-76.56-48.62-19.5-18.22
Upgrade
EBIT Margin
-6436.00%-609.75%-10423.72%-758.83%-1216.87%-819.11%-1916.50%--1949.60%-
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.